|
|
Article: Twice-weekly therapy not enough for co-infected, CDC says in advisory; changes will add `significant expense'.(Centers for Disease Control and Prevention)(Brief Article)
- Article from:
- TB Monitor
- Article date:
- April 1, 2002
CopyrightCOPYRIGHT 2002 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
TB patients with HIV and severe immune depression need daily therapy initially, and therapy three times weekly during the second phase of treatment, federal TB experts have decided. Otherwise, they may develop rifamycin resistance, according to surprising evidence from a new study.
The new directive issued by the Centers for Disease Control and Prevention's Division of TB Elimination (DTBE) is in effect at least until more data become available on the study findings, according to the Morbidity & Mortality Weekly Report for March 15, 2002. (1)
The new recommendation may pose a hardship for TB control programs already strapped for time and money. Many ...